Literature DB >> 17666212

Role of regulatory T cells and FOXP3 in human diseases.

Rosa Bacchetta1, Eleonora Gambineri, Maria-Grazia Roncarolo.   

Abstract

Immune regulation and tolerance are specific functions of the immune system, meaning at prevention or limitation of effector immune responses against inner and external insults. Regulatory T (Treg) cells are crucial players in this immune balance network. Research over the last 10 years has significantly contributed to characterizing Treg cell features, their mechanisms of function, and their role in human pathologies. The discovery of FOXP3 as an essential transcription factor not only for differentiation and function of naturally occurring Treg cells but also for regulation of intracellular molecules related to effector T-cell responses has provided new insights into the pathogenesis of immune-mediated diseases. Interestingly, there is increasing evidence that the individual signature of genes relevant for immune regulation definitely influences the final outcome of an immune response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666212     DOI: 10.1016/j.jaci.2007.06.023

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  74 in total

1.  Effects of oral glucocorticoid therapy on CD4+CD25+CD127- and CD4+CD25high T cell levels in asthmatic patients.

Authors:  Marcin Moniuszko; Anna Bodzenta-Lukaszyk; Milena Dabrowska
Journal:  Inflammation       Date:  2010-12       Impact factor: 4.092

2.  A clonal model for human CD8+ regulatory T cells: unrestricted contact-dependent killing of activated CD4+ T cells.

Authors:  Dan Hu; Xia Liu; Wanyong Zeng; Howard L Weiner; Jerome Ritz
Journal:  Eur J Immunol       Date:  2011-11-28       Impact factor: 5.532

3.  Molecular mechanisms of regulatory T cell development.

Authors:  Talal Chatila
Journal:  J Clin Immunol       Date:  2008-09-02       Impact factor: 8.317

4.  Novel and functional regulatory SNPs in the promoter region of FOXP3 gene in a Gabonese population.

Authors:  Susanne A Hanel; T P Velavan; Peter G Kremsner; Jürgen F J Kun
Journal:  Immunogenetics       Date:  2011-04-07       Impact factor: 2.846

Review 5.  Metabolic control of the Treg/Th17 axis.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

6.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

7.  Effects of nilotinib on regulatory T cells: the dose matters.

Authors:  Fei Fei; Yingzhe Yu; Anita Schmitt; Markus T Rojewski; Baoan Chen; Jochen Greiner; Marlies Götz; Donald Bunjes; Michael Schmitt
Journal:  Mol Cancer       Date:  2010-01-29       Impact factor: 27.401

8.  Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation.

Authors:  Parthav Jailwala; Jill Waukau; Sanja Glisic; Srikanta Jana; Sarah Ehlenbach; Martin Hessner; Ramin Alemzadeh; Shigemi Matsuyama; Purushottam Laud; Xujing Wang; Soumitra Ghosh
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

9.  A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.

Authors:  Karina M Melo; Karina I Carvalho; Fernanda R Bruno; Lishomwa C Ndhlovu; Wassim M Ballan; Douglas F Nixon; Esper G Kallas; Beatriz T Costa-Carvalho
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

10.  Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps.

Authors:  Geng Xu; Jiahong Xia; Xiaoyang Hua; Han Zhou; Chuanzhao Yu; Zheng Liu; Kemin Cai; Jianbo Shi; Huabin Li
Journal:  Respir Res       Date:  2009-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.